CPG 7909, an immunostimulatory TLR9 agonist oligodeoxynucleotide, as adjuvant to Engerix-B HBV vaccine in healthy adults: a double-blind phase I/II study
Cooper, C L, Davis, H L, Morris, M L, Efler, S M, Adhami, M Al, Krieg, A M, Cameron, D W, Heathcote, J
Published in Journal of clinical immunology (01.11.2004)
Published in Journal of clinical immunology (01.11.2004)
Get full text
Journal Article
P839: PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA TREATED WITH PEGCETACOPLAN SHOW IMPROVEMENTS IN D‐DIMER NORMALIZATION AND DECREASE IN INCIDENCE OF THROMBOSIS
Weitz, I., Al‐Adhami, M., Min, J., Persson, E., Yeh, M., Savage, J., Dingli, D.
Published in HemaSphere (23.06.2022)
Published in HemaSphere (23.06.2022)
Get full text
Journal Article
P838: PEGCETACOPLAN RAPIDLY STABILIZES COMPLEMENT INHIBITOR NAÏVE PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA EXPERIENCING HEMOLYSIS WITH ACUTE HEMOGLOBIN DECREASES; PRINCE TRIAL POST HOC ANALYSIS
Wong, R., Al‐Adhami, M., Savage, J., Horneff, R., Yeh, M., Dumagay, T., Gomez‐Almaguer, D.
Published in HemaSphere (23.06.2022)
Published in HemaSphere (23.06.2022)
Get full text
Journal Article
P833: CATEGORIZING HEMATOLOGICAL RESPONSE TO PEGCETACOPLAN IN PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA: A POST HOC ANALYSIS OF THE PHASE 3 PRINCE STUDY DATA
Risitano, A., Wong, R., Al‐Adhami, M., Savage, J., Horneff, R., Peffault de Latour, R.
Published in HemaSphere (23.06.2022)
Published in HemaSphere (23.06.2022)
Get full text
Journal Article
S303: EFFECT OF PEGCETACOPLAN ON QUALITY OF LIFE IN COMPLEMENT‐INHIBITOR NAÏVE PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA: RESULTS FROM THE PHASE 3 PRINCE STUDY
Gomez‐Almaguer, D., Wong, R., Dumagay, T., Al‐Adhami, M., Savage, J., Hakimi, Z., Bogdanovic, A.
Published in HemaSphere (01.06.2022)
Published in HemaSphere (01.06.2022)
Get full text
Journal Article
Safety and immunogenicity of CPG 7909 injection as an adjuvant to Fluarix influenza vaccine
Cooper, C.L, Davis, H.L, Morris, M.L, Efler, S.M, Krieg, A.M, Li, Y, Laframboise, C, Al Adhami, M.J, Khaliq, Y, Seguin, I, Cameron, D.W
Published in Vaccine (13.08.2004)
Published in Vaccine (13.08.2004)
Get full text
Journal Article
P828: NORMALIZATION OF HEMATOLOGIC AND HEALTH‐RELATED QUALITY OF LIFE MARKERS IN PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA TREATED WITH PEGCETACOPLAN AND BASELINE HEMOGLOBIN AT OR ABOVE 10 G/DL
Panse, J., Daguindau, N., Okuyama, S., Peffault de Latour, R., Schafhausen, P., Straetmans, N., Al‐Adhami, M., Ajayi, T., Persson, E., Yeh, M., Wong, R.
Published in HemaSphere (23.06.2022)
Published in HemaSphere (23.06.2022)
Get full text
Journal Article
Beyond Building Energy Simulation Tools
Delzendeh, E, Alaaeddine, R, Al-Adhami, M, Wu, S
Published in IOP conference series. Earth and environmental science (01.11.2020)
Published in IOP conference series. Earth and environmental science (01.11.2020)
Get full text
Journal Article
A phase III, randomized, double-blind, placebo (PBO)-controlled study of enzalutamide (ENZA) in men with nonmetastatic (M0) castration-resistant prostate cancer (CRPC): Results of PROSPER by age and region
Fizazi, K., Hussain, M., Saad, F., Shore, N., De Giorgi, U., Efstathiou, E., Ferreira, U., Ivashchenko, P., Madziarska, K., Al-Adhami, M., Modelska, K., Phung, D., Steinberg, J., Sternberg, C.N.
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
EMBRACA: Efficacy and safety in comparing talazoparib (TALA) with physician's choice of therapy (PCT) in patients (pts) with advanced breast cancer (aBC) and a germline BRCA mutation (gBRCAm); BRCA1/BRCA2 subgroup analysis
Gonçalves, A., Eiermann, W., Rugo, H.S., Ettl, J., Hurvitz, S.A., Yerushalmi, R., Martín, M., Al-Adhami, M., Tudor, I.C., Blum, J.L., Hannah, A.L., Litton, J.K.
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
A qualitative study on newly settled migrants’ perceptions of civic and health orientation in Sweden
Al-Adhami, M, Hjelm, K, Wångdahl, J, Larsson, E
Published in European journal of public health (21.10.2022)
Published in European journal of public health (21.10.2022)
Get full text
Journal Article
[649] CPG 10101 (ACTILON) IN COMBINATION WITH PEGYLATED INTERFERON AND/OR RIBAVIRIN IN CHRONIC HCV GENOTYPE 1 INFECTED PATIENTS WITH PRIOR RELAPSED RESPONSE: WEEK 48 DATA
Shiftman, M.L, Ghalib, R, Lawitz, E, Freilich, B, Gordon, S.C, Kwo, P.Y, Riley, T.R, Schiff, E, Flamm, S, Jacobson, I.M, Zein, N.N, Reuben, A, Swaim, M, Bright, D, Al-Adhami, M, Lekstrom-Himes, J, Massari, F.E, McHutchison, J.G
Published in Journal of hepatology (01.04.2007)
Published in Journal of hepatology (01.04.2007)
Get full text
Journal Article
The role of individual level health resources on health outcomes of newly settled migrants in Sweden
Al-Adhami, M, Berglund, E, Wångdahl, J, Hedrick, K, Salari, R
Published in European journal of public health (21.10.2022)
Published in European journal of public health (21.10.2022)
Get full text
Journal Article
608 Tivozanib biomarker identifies tumor infiltrating myeloid cells contributing to tivozanib resistance in both preclinical models and human renal cell carcinoma
Lin, J, Sun, X, Feng, B, Jiang, F, Li, G, Chiu, M.I, Esteves, B, Al-Adhami, M, Bhargava, P, Robinson, M.O
Published in European journal of cancer supplements (2010)
Published in European journal of cancer supplements (2010)
Get full text
Journal Article
Can extended health communication improve newly settled refugees’ health literacy? A quasi-experimental study from Sweden
Al-Adhami, Maissa, Durbeej, Natalie, Daryani, Achraf, Wångdahl, Josefin, Larsson, Elin C, Salari, Raziye
Published in Health promotion international (01.04.2024)
Published in Health promotion international (01.04.2024)
Get full text
Journal Article
"Putting words to their feelings"- civic communicators' perceptions and experiences of an in-depth course on mental health for newly settled refugee migrants in Sweden
Al-Adhami, Maissa, Wångdahl, Josefin, Salari, Raziye, Åkerman, Eva
Published in BMC health services research (19.05.2023)
Published in BMC health services research (19.05.2023)
Get full text
Journal Article
805PA phase III, randomized, double-blind, placebo (PBO)-controlled study of enzalutamide (ENZA) in men with nonmetastatic (M0) castration-resistant prostate cancer (CRPC): Results of PROSPER by age and region
Fizazi, K, Hussain, M, Saad, F, Shore, N, De Giorgi, U, Efstathiou, E, Ferreira, U, Ivashchenko, P, Madziarska, K, Al-Adhami, M, Modelska, K, Phung, D, Steinberg, J, Sternberg, C N
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article